Targeting PD-1 Therapy Resistance With Focused High or High and Low Dose Radiation in SCCHN
Targeting PD-1 Therapy Resistance With Focused High or High and Low Dose Radiation in SCCHN
Active, not recruiting · NCT03085719 · Registry updated 2026-06-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Targeting PD-1 Therapy Resistance With Focused High or High and Low Dose Radiation in SCCHN | Head and Neck Neoplasms, Neoplasms by Site, head and neck cancer, neoplasm | Active, not recruiting | Phase 2 | 2026-06-15 | NCT03085719 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dana-Farber Cancer Institute | 324 |
| Merck Sharp & Dohme LLC | 650 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dana Farber Cancer Institute | Boston | United States | 300 |